Cite
Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools.
MLA
Feng, Xiaoshuang, et al. “Lung Cancer Risk Discrimination of Prediagnostic Proteomics Measurements Compared with Existing Prediction Tools.” JNCI: Journal of the National Cancer Institute, vol. 115, no. 9, Sept. 2023, pp. 1050–59. EBSCOhost, https://doi.org/10.1093/jnci/djad071.
APA
Feng, X., Wu, W. Y.-Y., Onwuka, J. U., Haider, Z., Alcala, K., Smith-Byrne, K., Zahed, H., Guida, F., Wang, R., Bassett, J. K., Stevens, V., Wang, Y., Weinstein, S., Freedman, N. D., Chen, C., Tinker, L., Nøst, T. H., Koh, W.-P., Muller, D., & Colorado-Yohar, S. M. (2023). Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools. JNCI: Journal of the National Cancer Institute, 115(9), 1050–1059. https://doi.org/10.1093/jnci/djad071
Chicago
Feng, Xiaoshuang, Wendy Yi-Ying Wu, Justina Ucheojor Onwuka, Zahra Haider, Karine Alcala, Karl Smith-Byrne, Hana Zahed, et al. 2023. “Lung Cancer Risk Discrimination of Prediagnostic Proteomics Measurements Compared with Existing Prediction Tools.” JNCI: Journal of the National Cancer Institute 115 (9): 1050–59. doi:10.1093/jnci/djad071.